Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22801672 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Escitalopram for the Prevention of PEGASYS-associated Depression in Hepatitis C Virus-infected Patients
Condition: Depression
Interventions: Drug: Escitalopram;   Drug: Placebo;   Drug: Peginterferon alfa-2a;   Drug: Ribavirin

Indicates status has not been verified in more than two years